京东健康携手拜耳深耕消化道健康领域

Core Insights - JD Health and Bayer Health Consumer signed a strategic cooperation agreement for the promotion of Daxin® Lactulose, aiming to enhance the digestive health market in China [2][3] - The prevalence of chronic constipation in China is increasing, with an overall rate of 10.9%, and adult constipation rates reaching 13.4% from 2014 to 2018 [2] - Sales of laxative products in China grew from 4.573 billion to 7.683 billion yuan between 2017 and 2022, indicating a steady demand [2] Company Collaboration - JD Health will leverage its online channel advantages and full-channel business layout to enhance consumer awareness of Daxin® Lactulose [3] - The collaboration aims to expand offline retail channels and create a new ecosystem for online and offline coordinated growth [3] - Bayer Health Consumer values JD Health's integrated online and offline layout, seeking to provide quality products and services to more users [3] Product Features - Daxin® Lactulose is designed for long-term use, providing rapid clinical effects within 1-2 days for patients with chronic functional constipation [2] - The product has dual functions in the intestines, helping to lubricate and soften stools while promoting the growth of beneficial bacteria [2]